Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 98.36 USD -0.14% Market Closed
Market Cap: 249.3B USD
Have any thoughts about
Merck & Co Inc?
Write Note

Merck & Co Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merck & Co Inc
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
ZTS
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Merck & Co Inc
NYSE:MRK
Operating Income
$21.7B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
10%
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.2B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$11.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Operating Income
$13.1B
CAGR 3-Years
-17%
CAGR 5-Years
63%
CAGR 10-Years
-2%
Zoetis Inc
NYSE:ZTS
Operating Income
$3.3B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
13%
Eli Lilly and Co
NYSE:LLY
Operating Income
$14.4B
CAGR 3-Years
25%
CAGR 5-Years
21%
CAGR 10-Years
15%

See Also

What is Merck & Co Inc's Operating Income?
Operating Income
21.7B USD

Based on the financial report for Sep 30, 2024, Merck & Co Inc's Operating Income amounts to 21.7B USD.

What is Merck & Co Inc's Operating Income growth rate?
Operating Income CAGR 10Y
10%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Merck & Co Inc have been 20% over the past three years , 10% over the past five years , and 10% over the past ten years .

Back to Top